GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Gross Profit

Kimia Biosciences (BOM:530313) Gross Profit : ₹0.00 Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Gross Profit?

Kimia Biosciences's gross profit for the six months ended in . 20 was ₹0.00 Mil. Kimia Biosciences's gross profit for the trailing twelve months (TTM) ended in . 20 was ₹0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Kimia Biosciences's gross profit for the six months ended in . 20 was ₹0.00 Mil. Kimia Biosciences's Revenue for the six months ended in . 20 was ₹0.00 Mil. Therefore, Kimia Biosciences's Gross Margin % for the quarter that ended in . 20 was N/A%.

Kimia Biosciences had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Kimia Biosciences Gross Profit Historical Data

The historical data trend for Kimia Biosciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Gross Profit Chart

Kimia Biosciences Annual Data
Trend
Gross Profit

Kimia Biosciences Semi-Annual Data
Gross Profit

Competitive Comparison of Kimia Biosciences's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kimia Biosciences's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Gross Profit falls into.



Kimia Biosciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Kimia Biosciences's Gross Profit for the fiscal year that ended in . 20 is calculated as

Gross Profit (A: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Kimia Biosciences's Gross Profit for the quarter that ended in . 20 is calculated as

Gross Profit (Q: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Gross Profit for the trailing twelve months (TTM) ended in . 20 was ₹0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Kimia Biosciences's Gross Margin % for the quarter that ended in . 20 is calculated as

Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Kimia Biosciences  (BOM:530313) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Kimia Biosciences had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Kimia Biosciences Gross Profit Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines